GH
Guardant Health IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$10.90B
P/E Ratio
—
EPS
$-3.32
Beta
1.65
52W High
$120.74
52W Low
$36.36
50-Day MA
$90.44
200-Day MA
$83.01
Dividend Yield
—
Profit Margin
-42.40%
Forward P/E
—
PEG Ratio
—
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $982.02M |
| Gross Profit (TTM) | $633.01M |
| EBITDA | $-396.56M |
| Operating Margin | -42.90% |
| Return on Equity | -4584.00% |
| Return on Assets | -15.60% |
| Revenue/Share (TTM) | $7.83 |
| Book Value | $-0.76 |
| Price-to-Book | 55.67 |
| Price-to-Sales (TTM) | 11.10 |
| EV/Revenue | 12.34 |
| EV/EBITDA | -5.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.40% |
| Shares Outstanding | $131.17M |
| Float | $125.75M |
| % Insiders | 4.04% |
| % Institutions | 101.50% |
Historical Volatility
HV 10-Day
46.10%
HV 20-Day
64.41%
HV 30-Day
61.09%
HV 60-Day
56.04%
HV Rank
72.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($128.33 target)
5
Strong Buy16
Buy2
HoldData last updated: 4/29/2026